The array data further established that there is remarkable decrease in NOSTRIN expression right at the onset of the disease as it was evident from our results that early stages of the colon cancer showed reduced NOSTRIN expression compared to the normal colonic samples indicating its probable role as a marker of disease aggressiveness. The gene discussed is NOSTRIN; the disease is colonic neoplasm.